Besides, we knocked down KLK11 in mouse hearts and observed that KLK11 loss suppressed TAC-induced decrease in heart function (fraction shortening and ejection fraction) and increase in heart weight, cardiomyocyte size, as well as overexpression of fetal genes associated with cardiac hypertrophy. This evidence concerns the gene KLK11 and cardiac hypertrophy.